SAVA Cassava Sciences

Watchlist

2.840
+0.080+2.90%

Close Mar 21 16:00 ET

2.801
-0.039-1.37%

Post 20:01 ET

137.19MMarket Cap-1.95P/E (TTM)

About Cassava Sciences Company

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

Company Profile

SymbolSAVA

Company NameCassava Sciences

Listing DateJul 14, 2000

Issue Price12.00

Founded1998

CEOMr. Richard J. Barry

MarketNASDAQ

Employees30

Fiscal Year Ends12-31

Address6801 North Capital of Texas Highway,Suite 300

CityAustin

ProvinceTexas

CountryUnited States of America

Zip Code78731

Phone1-512-501-2444

Websitehttp://www.cassavasciences.com

Company Executives

Name
Position
Salary

Richard J. Barry
President, Chief Executive Officer and Director
546.16K

Dr. James W. Kupiec, M.D.
Chief Medical Officer and Chief Clinical Development Officer
2.97M

Eric Schoen
Chief Financial Officer and Principal Accounting Officer
2.99M

R. Christopher Cook
Senior Vice President and General Counsel
1.27M

Dr. Claude Nicaise,M.D.
Chairman of the Board
474.50K

Sanford R. Robertson
Lead Independent Director
546.16K

Dr. Patrick J. Scannon,M.D.,PhD
Independent Director
438.42K

Dr. Robert Z. Gussin, PhD
Independent Director
546.16K

Robert Anderson, Jr
Independent Director
474.50K

Michael J. O'Donnell, Esq.
Independent Director
438.42K

Pierre Gravier
Independent Director
474.50K

SAVA Cassava Sciences

About Cassava Sciences Company

Company Profile

Company Executives

Market Insights